| Code | Description | Claims | Beneficiaries | Total Paid |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
10,998 |
10,730 |
$812K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
6,981 |
6,974 |
$721K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
8,129 |
8,124 |
$678K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
9,329 |
8,877 |
$440K |
| 92551 |
|
24,173 |
24,043 |
$439K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,946 |
4,821 |
$361K |
| G9920 |
Screening performed and negative |
9,815 |
9,799 |
$284K |
| 90686 |
|
13,572 |
13,493 |
$248K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
5,672 |
5,657 |
$247K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
8,905 |
8,887 |
$217K |
| 90636 |
|
2,084 |
2,074 |
$212K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,957 |
2,851 |
$203K |
| 96127 |
|
18,392 |
18,226 |
$129K |
| 90715 |
|
4,990 |
4,978 |
$128K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,168 |
1,155 |
$128K |
| 90620 |
|
2,891 |
2,887 |
$125K |
| 90651 |
|
3,275 |
3,265 |
$118K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,423 |
2,322 |
$115K |
| 99406 |
|
7,294 |
7,228 |
$112K |
| 87634 |
|
1,894 |
1,786 |
$106K |
| 99173 |
|
19,817 |
19,740 |
$99K |
| 99188 |
|
3,669 |
3,544 |
$98K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
86,897 |
75,517 |
$97K |
| 98960 |
|
2,161 |
2,078 |
$86K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
670 |
668 |
$78K |
| 91322 |
|
601 |
564 |
$64K |
| 90734 |
|
2,804 |
2,796 |
$55K |
| 90648 |
|
2,636 |
2,593 |
$47K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
490 |
488 |
$45K |
| 90670 |
|
2,153 |
2,104 |
$42K |
| 90716 |
|
1,931 |
1,881 |
$42K |
| 90707 |
|
1,823 |
1,781 |
$38K |
| 90633 |
|
1,763 |
1,709 |
$31K |
| 90480 |
|
782 |
782 |
$30K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
2,070 |
2,066 |
$29K |
| 90723 |
|
1,561 |
1,539 |
$28K |
| 85018 |
|
13,024 |
12,732 |
$27K |
| 90656 |
|
1,245 |
1,245 |
$25K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
832 |
830 |
$24K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,734 |
8,270 |
$20K |
| 76830 |
Ultrasound, transvaginal |
203 |
203 |
$18K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
661 |
661 |
$16K |
| 0124A |
|
283 |
282 |
$11K |
| 81025 |
|
3,804 |
3,670 |
$11K |
| 81000 |
|
4,586 |
4,327 |
$10K |
| 90677 |
|
408 |
408 |
$9K |
| 90696 |
|
461 |
456 |
$8K |
| 90674 |
|
393 |
388 |
$8K |
| 81002 |
|
4,290 |
4,158 |
$8K |
| 90681 |
|
430 |
428 |
$8K |
| 99385 |
|
200 |
200 |
$7K |
| 99381 |
|
79 |
78 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
763 |
759 |
$6K |
| G9919 |
Screening performed and positive and provision of recommendations |
201 |
201 |
$6K |
| 0054A |
|
140 |
140 |
$6K |
| 91321 |
|
80 |
70 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
335 |
333 |
$5K |
| 0064A |
|
122 |
122 |
$5K |
| 86580 |
|
1,088 |
1,048 |
$5K |
| 0011A |
|
112 |
112 |
$4K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
125 |
125 |
$4K |
| 99383 |
|
41 |
41 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,170 |
4,010 |
$4K |
| 0012A |
|
104 |
104 |
$4K |
| 0134A |
|
88 |
88 |
$4K |
| 90700 |
|
170 |
170 |
$3K |
| 83655 |
|
252 |
241 |
$3K |
| 0072A |
|
62 |
62 |
$2K |
| 0071A |
|
51 |
51 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
48 |
48 |
$1K |
| 99384 |
|
12 |
12 |
$1K |
| 76770 |
|
13 |
13 |
$1K |
| 90713 |
|
29 |
29 |
$1K |
| 0052A |
|
24 |
24 |
$960.00 |
| 0051A |
|
18 |
18 |
$720.00 |
| 99462 |
|
19 |
14 |
$688.98 |
| 0154A |
|
17 |
17 |
$680.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
340 |
339 |
$487.06 |
| 82962 |
|
261 |
258 |
$481.51 |
| 0111A |
|
12 |
12 |
$480.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,313 |
2,308 |
$231.65 |
| 93000 |
|
36 |
36 |
$183.35 |
| 69210 |
|
17 |
16 |
$45.79 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
200 |
200 |
$4.46 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
12 |
12 |
$0.02 |
| 1036F |
|
9,546 |
9,477 |
$0.00 |
| 3074F |
|
17 |
13 |
$0.00 |
| 3079F |
|
32 |
32 |
$0.00 |
| 3077F |
|
14 |
13 |
$0.00 |
| 3078F |
|
16 |
14 |
$0.00 |
| 90461 |
|
13 |
13 |
$0.00 |